ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Pre-, Intra-, and Post-Operative Pearls for the MicroShunt"
Episode Synopsis
In this special episode of GT: The Podcast, made possible with support from Santen Pharmaceuticals, Ike Ahmed, MD; George Durr, MD; and Ticiana De Francesco, MD, share lessons learned on their use of the MicroShunt since its release. Together, they offer pre-operative, intra- operative, and post-operative suggestions, tips for patient selection, proper positioning, and more based on the retrospective clinical studies conducted, in part, by Dr. Durr and Dr. Ahmed.1,2
1. Durr GM, Schlenker MB, Samet S, Ahmed IIK. One-year outcomes of stand-alone ab externo SIBS MicroShunt implantation in refractory glaucoma. Br J Ophthalmol. 2020. Available at: bjophthalmol-2020-317299. Epub ahead of print.
2. Schlenker MB, Durr GM, Michaelov E, Ahmed IIK. Intermediate outcomes of a novel standalone ab externo SIBS MicroShunt with mitomycin c. Am J Ophthalmol. 2020;215:141-153.
1. Durr GM, Schlenker MB, Samet S, Ahmed IIK. One-year outcomes of stand-alone ab externo SIBS MicroShunt implantation in refractory glaucoma. Br J Ophthalmol. 2020. Available at: bjophthalmol-2020-317299. Epub ahead of print.
2. Schlenker MB, Durr GM, Michaelov E, Ahmed IIK. Intermediate outcomes of a novel standalone ab externo SIBS MicroShunt with mitomycin c. Am J Ophthalmol. 2020;215:141-153.
More episodes of the podcast GT: The Podcast
The Role of Anterior Segment OCT in MIGS
22/08/2025
A Cilioscleral Interpositioning Device
28/07/2025
Metabolic Dysfunction in Glaucoma
28/04/2025
In God we trust